Copyright
©The Author(s) 2021.
World J Hepatol. Feb 27, 2021; 13(2): 166-186
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.166
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.166
Ref. | Studies included | Patients, n | Procedures | Results |
Almadi et al[62], 2017 | 20 | 1713 | Endoscopic or percutaneous palliative biliary drainage with plastic stent vs SEMS | Stent patency 4.45 mo (95%CI: 0.31-8.59) in favor of SEMS; Overall survival 0.67 (95%CI: 0.66-1.99), no difference |
Moole et al[33], 2017 | 11 | 947 | Endoscopic palliative biliary drainage with plastic stent vs SEMS | Stent occlusion OR 0.48 (95%CI: 0.34-0.67) in favor of SEMS; Overall survival/time to death: (1) SEMS, 157.3 d (95%CI: 148.9-165.6), (2) Plastic, 120.6 d (95%CI: 114.3-126.9), P = 0.0024 |
Zorrón Pu et al[64], 2015 | 13 | 1133 | Endoscopic palliative biliary drainage with plastic stent vs SEMS | Stent dysfunction, RD -0.26 (95%CI: -0.32 to -0.20) in favor of SEMS; Survival longer in the SEMS group (187 d vs 162 d, P < 0.0001) |
Sawas et al[65], 2015 | 19 | 1989 | Endoscopic or percutaneous palliative biliary drainage with plastic stent vs SEMS | Stent occlusion, HR 0.42 (95%CI: 0.27-0.64) in favor of SEMS; 30-d survival, HR 0.82 (95%CI: 0.45-1.48), no difference |
Hong et al[66], 2013 | 10 | 785 | Endoscopic palliative biliary drainage with plastic stent vs SEMS | Stent patency, HR 0.37 (95%CI: 0.28-0.48) in favor of SEMS; Survival, HR 0.81 (95%CI: 0.68-0.96) in favor of SEMS |
- Citation: Tantau AI, Mandrutiu A, Pop A, Zaharie RD, Crisan D, Preda CM, Tantau M, Mercea V. Extrahepatic cholangiocarcinoma: Current status of endoscopic approach and additional therapies. World J Hepatol 2021; 13(2): 166-186
- URL: https://www.wjgnet.com/1948-5182/full/v13/i2/166.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i2.166